Skip to main content

Gout clinical trials at UCLA

3 in progress, 0 open to eligible people

Showing trials for
  • Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout

    Sorry, accepting new patients by invitation only

    This safety and feasibility, open-label study of up to 9 subjects will examine a group of subjects with poorly controlled tophaceous gout (intolerant to or ineffective oral urate lowering agents and loss of prior Pegloticase response) pre-treated with Rituximab to recapture response to Methotrexate-Pegloticase.

    Los Angeles, California

  • UR+AIMS Gout Wearable Skin Uric Acid Monitor Study

    Sorry, not yet accepting patients

    15 patients with gout [10 patients no recent urate-lowering therapy (ULT) and 5 patients on stable urate-lowering therapy (ULT)] will be invited to participate in a standardized meal at the UCLA Human Nutrition Center and a 7-day community follow-up for the measurement of uric acid (and other metabolites) using our Uric Acid and Metabolite Monitor System (UR+AIMS) skin patch.

    Los Angeles, California

  • Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

    Sorry, not currently recruiting here

    The TRUST study is a randomized, controlled multicenter study to evaluate the management of gout by comparing two commonly used treatment strategies for gout (TTT vs TTASx) to determine the most beneficial for a patient-centered gout outcomes, as well as relevant cardiovascular-metabolic-renal endpoints.

    Santa Monica, California and other locations

Our lead scientists for Gout research studies include .

Last updated: